Login
Israel-Hamas Conflict
Independence Day
Social Media
Donald Trump
Formula 1
Soccer
Infrastructure
Natural Disasters
World Cup
Artificial Intelligence
Education
Tour De France
Parade
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published • loading... • Updated

Multi-Center NIH Research Trial Evaluating GALAD, a Novel Blood-Based Algorithm, in the Early Detection of Liver Cancer

Summary by Post Register
LEXINGTON, Mass.--(BUSINESS WIRE)--Jun 18, 2025-

2 Articles

All
Left
Center
2
Right
Daily EchoDaily Echo
Center

'A great trip back to independence' - Alan’s liver trial journey

The retired support worker suffers from refractory ascites, a painful, recurrent fluid build-up caused by cirrhosis.

·Southampton, United Kingdom
Read Full Article
Post RegisterPost Register
Center

Multi-Center NIH Research Trial Evaluating GALAD, a Novel Blood-Based Algorithm, in the Early Detection of Liver Cancer

LEXINGTON, Mass.--(BUSINESS WIRE)--Jun 18, 2025-

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Post Register broke the news in on Wednesday, June 18, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Lexington, Massachusetts icon

Lexington, Massachusetts

England icon

England

You have read 1 out of your 5 free daily articles.

News
For You
SearchBlindspotLocal